Primary pulmonary hypertension is not associated with scleroderma-like changes in nailfold capillaries

Chest

Volumn 120, Issue 3, 2001, Pages 796-800

  Greidinger, Eric L ^a   Gaine, Sean P ^c   Wise, Robert A ^c   Boling, Christy ^b   Housten Harris, Traci ^c  

^a UNIVERSITY OF MISSOURI   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Nailfold capillaroscopy; Primary pulmonary hypertension; Scleroderma

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; CAPILLAROSCOPY; CAPILLARY; CASE CONTROL STUDY; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FINGER NAIL; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCLERODERMA; VASCULAR DISEASE;

EID: 0034833783     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.120.3.796     Document Type: Article

References (23)

1. Pathology and pathophysiology of primary pulmonary hypertension
2. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family
3. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis
4. Mortality and causes of death in a Swedish series of systemic sclerosis patients
5. Pulmonary artery adventitial changes and venous involvement in primary pulmonary hypertension
6. Pulmonary arterial histology and morphometry in systemic sclerosis: A case-control autopsy study
7. Primary pulmonary hypertension: A national prospective study
8. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension: The Primary Pulmonary Hypertension Study Group
9. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized, controlled trial
10. Genetics and immunogenetic aspects of primary pulmonary hypertension
11. Nailfold capillary abnormalities
12. Blind evaluation of the diagnostic specificity of nailfold capillary microscopy in the connective tissue diseases
13. The evolution of Raynaud's phenomenon: A long-term prospective study
14. Anorexigens and pulmonary hypertension in the United States: Results from the Surveillance of North American Pulmonary Hypertension
15. Preliminary criteria for the classification of systemic sclerosis (scleroderma): Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostics and Therapeutics Criteria Committee
16. Geographic variation in the prevalence of Raynaud's phenomenon: A 5 region comparison
17. Behavioral and pharmacologic interventions: The Raynaud's Treatment Study
18. Widefield capillary microscopy
19. The measurement of observer agreement for categorical data
20. Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls
21. In vivo capillary microscopy findings and ophthalmoscopy findings in scleroderma
22. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacylin) therapy in primary pulmonary hypertension
23. Intermittent epoprostenol (prostacyclin) infusion in patients with Raynaud's syndrome: A double-blind controlled trial